Dark
Light
Today: October 8, 2024
September 30, 2024
1 min read

Arch Venture Partners secures over $3bn for Fund XIII

TLDR:

  • Arch Venture Partners has raised over $3 billion for Fund XIII.
  • Investors in the fund include Alaska Permanent Fund and Rockefeller Brothers Fund.

In a recent development, Arch Venture Partners has successfully raised over $3 billion for Fund XIII. This significant fundraising effort has caught the attention of prominent investors such as Alaska Permanent Fund and Rockefeller Brothers Fund. The fund is expected to focus on investments in the biotech and life sciences sectors, highlighting the increasing interest in these fields among investors.

This substantial fundraising achievement reflects the confidence investors have in Arch Venture Partners and their expertise in identifying promising opportunities in the market. With the backing of reputable investors like Alaska Permanent Fund and Rockefeller Brothers Fund, Fund XIII is poised to make a significant impact in the biotech and life sciences industries.

Overall, the successful fundraising for Fund XIII by Arch Venture Partners showcases the continued interest and support for investments in innovative sectors such as biotech and life sciences. With the backing of key investors, the fund is well-positioned to capitalize on emerging opportunities and drive growth in these dynamic industries.

Previous Story

Raising Your First Venture Fund: Tips for Success

Latest from Blog

Growing Cerity Partners: Merging with $15B VC Firm

TLDR: Cerity Partners merges with Touchdown Ventures, expanding venture capital capabilities Merge will enhance offerings to corporations and businesses, as well as private clients Cerity Partners, an independent wealth management firm, has
Go toTop